المؤلفون: V. E. Korelina, I. N. Semizorova, I. R. Gazizova, Z. M. Nagornova, В. Е. Корелина, И. Н. Семизорова, И. Р. Газизова, З. М. Нагорнова

المصدر: National Journal glaucoma; Том 23, № 2 (2024); 70-78 ; Национальный журнал Глаукома; Том 23, № 2 (2024); 70-78 ; 2311-6862 ; 2078-4104

مصطلحات موضوعية: психотерапия, retinal ganglion cells, cognitive impairment, psychotherapy, ганглиозные клетки сетчатки, когнитивные нарушения

وصف الملف: application/pdf

Relation: https://www.glaucomajournal.ru/jour/article/view/526/469; Лосев А.Ф., Тахо-Годи А.А. Платон. Диалоги. Пер. с древнегреч. М: Мысль 1986; 607.; Зураева А.М., Джелиева З. Т. Психотерапевтическая работа с больными, имеющими хронические заболевания. Азимут научных исследований: педагогика и психология 2018; 2(23):367-369.; Evans-Lacko S., Aguilar-Gaxiola S., Al-Hamzawi A. et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med 2018; 48(9):1560- 1571. https://doi.org/10.1017/S0033291717003336.; Rockwood K., Macknight C., Wentzel C. et al. The diagnosis of «mixed» dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann. N.Y. Acad. Sci. 2000; 903:522-528. https://doi.org/10.1111/j.1749-6632.2000.tb06408.x.; Акимова Е.В., Гафаров В.В., Гакова Е.И., Акимов А.М., Каюмова М.М. Изучение связи депрессии и ишемической болезни сердца у мужчин и женщин открытой популяции среднеурбанизированного города Западной Сибири. Кардиоваскулярная терапия и профилактика 2021; 20(2):2557. https://doi.org/10.15829/1728-8800-2021-2557.; Vaccarino V., Badimon L., Bremner J.D. et al. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J 2020; 41(17):1687-1696. https://doi.org/10.1093/eurheartj/ehy913.; Tang B., Yuan S., Xiong Y. et al. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study. Diabetologia 2020; 63(7):1305-1311.; Менделевич Е.Г. Хроническая мозговая сосудистая недостаточность: клинико-нейровизуализационные параметры, факторы риска и нейро-протективная терапия. РМЖ. 2016; 7:424-428.; Михайлов В.А. Терапия непсихотических психических расстройств в практике невролога. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева 2014; 4:100-105.; Tariot P.N., Farlow M.R., Grossberg G.T. et al. Memantine treatment in patients with moderate-to-severe Alzheimer disease already receiving donepizil: a randomized controlled trial. JAMA 2004; 291(3):317-324. https://doi.org/10.1001/jama.291.3.317.; Lippi G., Sanchis-Gomar F., Mattiuzzi C., Lavie C.J. Estimating Worldwide Impact of Low Physical Activity on Risk of Developing Ischemic Heart Disease-Related Disability: An Updated Search in the 2019 Global Health Data Exchange (GHDx). Medicines (Basel) 2022; 9(11):55. https://doi.org/10.3390/medicines9110055.; Lee J.Y., Kim J.M., Kim S.H. et al. Epidemiologic Survey Committee of the Korean Ophthalmological Society. Associations Among Pregnancy, Parturition, and Open-angle Glaucoma: Korea National Health and Nutrition Examination Survey 2010 to 2011. J Glaucoma 2019; 28(1):14-19. https://doi.org/10.1097/IJG.0000000000001101.; Корелина В.Е., Газизова И.Р. Возрастные аспекты приверженности терапии глаукомы. Эффективная фармакотерапия 2021; 17(37):34-39. https://doi.org/10.33978/2307-3586-2021-17-37-34-39.; Jean-Louis G., Zizi F., Lazzaro D.R., Wolintz A.H. Circadian rhythm dysfunction in glaucoma: A hypothesis. Journal of Circadian Rhythms 2008; 6:1. https://doi.org/10.1186/1740-3391-6-1.; Panda S., Nayak S.K., Campo B. et al. Illumination of the melanopsin signaling pathway. Science 2005; 28; 307(5709):600-604. https://doi.org/10.1126/science.1105121.; Drouyer E., Dkhissi-Benyahya O., Chiquet C. et al. Glaucoma alters the circadian timing system. PLoS One 2008; 3(12):e3931. https://doi.org/10.1371/journal.pone.0003931.; Губин Д.Г., Малишевская Т.В., Вайнерт Д. и др. Особенности циркадианного ритма внутриглазного давления при стабильной и прогрессирующей первичной открытоугольной глаукоме. Тюменский медицинский журнал 2018; 20(3):3-9.; Козина Е.В. Влияние биологической обратной связи на интраокулярную гемодинамику больных первичной открытоугольной начальной глаукомой. Сибирское медицинское обозрение 2006; 42(5):20-22.; Otori Y., Takahashi G., Urashima M., Kuwayama Y. Evaluating the quality of life of glaucoma patients using the state-trait anxiety inventory. J Glaucoma 2017; 26(11):1025-1029. https://doi.org/10.1097/IJG.0000000000000761.; Takahashi G ., Otori Y., Urashima M. et al. Evaluation of quality of life in Japanese glaucoma patients and its relationship with visual function. J Glaucoma 2016; 25(3):150-56. https://doi.org/10.1097/IJG.0000000000000221.; Габдрахманов Л.М., Газизова И.Р., Селезнев А.В. и др. Психология глаукомного больного. Российский офтальмологический журнал 2020; 13(3):92-96. https://doi.org/10.21516/2072-0076-2020-13-3-92-96; Doustar J., Torbati T., Black K.L., Koronyo Y., Koronyo-Hamaoui M. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. Front Neurol 2017; 19(8):701. https://doi.org/10.3389/fneur.2017.00701.; Grimaldi A., Brighi C., Peruzzi G. et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model. Cell Death Dis 2018; 9(6):685. https://doi.org/10.1038/s41419-018-0740-5.; Лобзин В.Ю., Мальцев Д.С., Струментова Е.С., Бурнашева М.А., Черемисин С.С. Офтальмологические маркеры болезни Альцгеймера. Медицинский алфавит 2022; 1:47-53. https://doi.org/10.33667/2078-5631-2022-1-47-53.; Martucci A., Picchi E., Di Giuliano F. et al. Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices. Curr Opin Pharmacol 2022; 62:137-144. https://doi.org/10.1016/j.coph.2021.12.003.; De Lau L.M., Breteler M.M. Epidemiology of Parkinson’s disease. Lancet Neurol 2006; 5(6):525-535. https://doi.org/10.1016/S1474-4422(06)70471-9.; Guzman-Martinez L., Maccioni R.B., Farías G.A., Fuentes P., Navarrete L.P. Biomarkers for Alzheimer's Disease. Curr Alzheimer Res 2019; 16(6):518-528. https://doi.org/10.2174/1567205016666190517121140.; Wostyn P., Audenaert K., De Deyn P.P. Alzheimer's disease and glaucoma: is there a causal relationship? Br J Ophthalmol 2009; 93(12): 1557-1559. https://doi.org/10.1136/bjo.2008.148064.; Bayer A.U., Ferrari F., Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002; 47(3):165-168. https://doi.org/10.1159/000047976.; Tamura H., Kawakami H., Kanamoto T. et al. High frequency of openangle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006; 246(1-2):79-83. https://doi.org/10.1016/j.jns.2006.02.009.; Yoneda S., Hara H., Hirata A. et al. Vitreous fluid levels of beta-amyloid(1-42) and tau in patients with retinal diseases. Jpn J Ophthalmol 2005; 49(2):106-108. https://doi.org/10.1007/s10384-004-0156-x.; Nucci C., Martucci A., Martorana A., Sancesario G.M., Cerulli L. Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins. Clin Exp Ophthalmol 2011; 39(3):279-281. https://doi.org/10.1111/j.1442-9071.2010.02452.x.; Bayer A.U., Ferrari F., Erb C. High occurrence rate of glaucoma among patients with Alzheimer’s disease. Eur Neurol 2002; 47:165-168. https://doi.org/10.1159/000047976.; Trick G.L., Trick L.R., Morris P., Wolf M. Visual field loss in senile dementia of the Alzheimer’s disease type. Neurology 1995; 45:68-74. https://doi.org/10.1212/wnl.45.1.68.; Den Haan J., Verbraak F.D., Visser P.J., Bouwman F.H. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis. Alzheimers Dement (Amst) 2017; 6:162-170. https://doi.org/10.1016/j.dadm.2016.12.014.; Cerquera-Jaramillo M.A., Nava-Mesa M.O., González-Reyes R.E. et al. Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview. Neural Plast 2018; 14:2941783. https://doi.org/10.1155/2018/2941783.; Jones-Odeh E., Hammond C.J. How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis? Eye (Lond) 2015; 29(10):1270-1284. https://doi.org/10.1038/eye.2015.158.; Егоров Е.А., Корелина В.Е., Чередниченко Д.В., Газизова И.Р. Роль нейровоспаления в патогенезе глаукомной оптической нейропатии. Клиническая офтальмология 2022; 22(2):116-121. https://doi.org/10.32364/2311-7729-2022-22-2-116-121.; Mullany S., Xiao L., Qassim A. et al. Normal-tension glaucoma is associated with cognitive impairment. Br J Ophthalmol 2022; 106(7):952-956. https://doi.org/10.1136/bjophthalmol-2020-317461.; Chen Y.Y., Lai Y.J., Yen Y.F. et al. Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan. BMJ Open 2018; 8(11):e022987. https://doi.org/10.1136/bmjopen-2018-022987.; Lai S.W., Lin C.L., Liao K.F. Glaucoma may be a non-memory manifestation of Alzheimer's disease in older people. Int Psychogeriatr 2017; 29:1-7. https://doi.org/10.1017/S1041610217000801.; Kessing L.V., Lopez A.G., Andersen P.K., Kessing S.V. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma 2007; 16(1):47-51. https://doi.org/10.1097/IJG.0b013e31802b3527.; Lee C.S., Larson E.B., Gibbons L.E. et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease. Alzheimers Dement 2019; 15(1):34-41. https://doi.org/10.1016/j.jalz.2018.06.2856; Nasreddine Z.S., Phillips N.A., Bédirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4):695-9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.; Davis D.H., Creavin S.T., Yip J.L. et al. Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias. Cochrane Database Syst Rev 2015; 10:CD010775. https://doi.org/10.1002/14651858.CD010775.pub2.; Iseri P.K., Altinaş O., Tokay T., Yüksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26(1):18-24. https://doi.org/10.1097/01.wno.0000204645.56873.26.; Ferrari L., Huang S.C., Magnani G. et al. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease. J Alzheimers Dis 2017; 56(3):1101-1107. https://doi.org/10.3233/JAD-160886.; Almeida A.L.M., Pires L.A., Figueiredo E.A. Correlation between cognitive impairment and retinal neural loss assessed by swept-source optical coherence tomography in patients with mild cognitive impairment. Alzheimers Dement (Amst) 2019; 11:659-669. https://doi.org/10.1016/j.dadm.2019.08.006.; Ito Y., Sasaki M., Takahashi H. et al. Quantitative Assessment of the Retina Using OCT and Associations with Cognitive Function. Ophthalmology 2020; 127(1):107-118. https://doi.org/10.1016/j.ophtha.2019.05.021.; Ward D.D., Mauschitz M.M., Bönniger M.M. et al. Association of retinal layer measurements and adult cognitive function: A populationbased study. Neurology 2020; 95(9):e1144-e1152. https://doi.org/10.1212/WNL.0000000000010146.; Rezapour J., Nickels S., Schuster A.K. et al. Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study. BMC Ophthalmol 2018; 18(1):157. https://doi.org/10.1186/s12886-018-0831-1.; Richards S.H., Anderson L., Jenkinson C.E. et al. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. Eur J Prev Cardiol 2018; 25(3):247-259. https://doi.org/10.1177/2047487317739978.; Conversano C., Orrù G., Pozza A. et al. Is Mindfulness-Based Stress Reduction Effective for People with Hypertension? A Systematic Review and Meta-Analysis of 30 Years of Evidence. Int J Environ Res Public Health 2021; 18(6):2882. https://doi.org/10.3390/ijerph18062882.; Larionov P. Psychological methods in treatment of essential hypertension. Arterial Hypertension 2021; 25(2):53-62. https://doi.org/10.5603/AH.a2021.0002; Sabel B.A., Wang J., Cárdenas-Morales L., Faiq M., Heim C. Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA J 2018; 9(2):133-160. https://doi.org/10.1007/s13167-018-0136-8.; Bertelmann T., Strempel I. Psychotherapeutic treatment options in glaucoma patients. Klin Monbl Augenheilkd 2021; 238(2):153-160. https://doi.org/10.1055/a-1244-6242.; Dada T., Mondal S., Midha N. et al. Effect of Mindfulness-Based Stress Reduction on Intraocular Pressure in Patients With Ocular Hypertension: A Randomized Control Trial. Am J Ophthalmol 2022; 239:66-73. https://doi.org/10.1016/j.ajo.2022.01.017.; Dada T., Bhai N., Midha N. et al. Effect of Mindfulness Meditation on Intraocular Pressure and Trabecular Meshwork Gene Expression: A Randomized Controlled Trial. Am J Ophthalmol 2021; 223:308-321. https://doi.org/10.1016/j.ajo.2020.10.012.; Корелина В.Е. Изучение коррекции перекисного окисления липидов антиоксидантами при экспериментальной глаукоме (экспериментальное исследование). Автореф. дисс. канд. мед. наук. 1999: 19.; Алексеев В.Н., Корелина В.Е., Шаша Ч. Нейропротекция новым антиоксидантом Рексод при экспериментальной глаукоме. Клиническая офтальмология 2008; 3:82-83.; Bredesen D.E., Sharlin K., Jenkins D. et al. Reversal of Cognitive Decline: 100 Patients. J Alzheimers Dis Parkinsonism 2018; 8:450. https://doi.org/10.4172/2161-0460.1000450.; Konkolÿ Thege B., Petroll C., Rivas C., Scholtens S. The Effectiveness of Family Constellation Therapy in Improving Mental Health: A Systematic Review. Fam Process 2021; 60(2):409-423. https://doi.org/10.1111/famp.12636.; Leaviss J., Davis S., Ren S. et al. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Health Technol Assess. 2020; 24(46):1-490. https://doi.org/10.3310/hta24460; https://www.glaucomajournal.ru/jour/article/view/526

الاتاحة: https://www.glaucomajournal.ru/jour/article/view/526
https://doi.org/10.53432/2078-4104-2024-23-2-70-78